Carbamic Acid

Carbamic Acid

SCHEMBL6466030

NC(=O)O.O=C(O)N(Cc1ccccc1)Cc1ccccc1

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.57
KDM4E B2RXH2 1/20 0.56
ALDH1A1 P00352 3/20 0.55
NPSR1 Q6W5P4 1/20 0.55
TSHR P16473 1/20 0.53
GRIN2D O15399 1/20 0.53
GRIN3B O60391 1/20 0.53
GRIN1 Q05586 1/20 0.53
GRIN2A Q12879 1/20 0.53
GRIN2B Q13224 1/20 0.53
GRIN2C Q14957 1/20 0.53
GRIN3A Q8TCU5 1/20 0.53
MEN1 O00255 3/20 0.52
KMT2A Q03164 3/20 0.52
TDP1 Q9NUW8 1/20 0.52
MGLL Q99685 1/20 0.50
MAPT P10636 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
REN P00797 1/20 0.49
NPC1 O15118 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL825414 0.93 LMNA (0.63) LMNAKDM4EALDH1A1NPSR1TSHR
SCHEMBL673623 0.91 LMNA (0.61) LMNAKDM4EALDH1A1NPSR1TSHR
SCHEMBL149160 0.91 LMNA (0.61) LMNAKDM4EALDH1A1NPSR1TSHR
SCHEMBL638764 0.91 LMNA (0.61) LMNAKDM4EALDH1A1NPSR1TSHR
SCHEMBL672047 0.91 LMNA (0.61) LMNAKDM4EALDH1A1NPSR1TSHR
SCHEMBL8718249 0.91 LMNA (0.61) LMNAKDM4EALDH1A1NPSR1TSHR
SCHEMBL1386528 0.86 LMNA (0.57) LMNAKDM4EALDH1A1NPSR1TSHR
SCHEMBL864165 0.85 LMNA (0.52) LMNAKDM4EALDH1A1NPSR1TSHR
SCHEMBL4018453 0.85 LOXL2 (0.56) LMNAKDM4EALDH1A1NPSR1TSHR
SCHEMBL1500719 0.84 LMNA (0.55) LMNAKDM4EALDH1A1NPSR1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050203176-A1 Carbamates as HIV anti-viral agents WYETH (US) 2005-09-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050203176-A1 Carbamates as HIV anti-viral agents RNASEH1, CTSH, RNASE1 LMNA 2574/4885KDM4E 104/4885ALDH1A1 2591/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.